Sandeep Mehta

Sandeep has been with JSA since 2008 as a partner. Sandeep specializes in foreign investments, mergers and acquisitions, joint ventures, collaborations, technology transfers, takeovers, business transfers, private equity and corporate restructuring transactions. He has been advising Indian and foreign clients on corporate, commercial, employment and real estate laws and related transaction matters.

He has been practising law since 1994. He was a partner for over six years with Little & Co., Advocates & Solicitors from 2001 and working with then since 1992.

 

Recognition

  • Chambers and Partners has ranked Sandeep as a leading lawyer in the Corporate and Mergers & Acquisitions space.
  • Asia Law Profiles has identified Sandeep as an outstanding lawyer for Corporate and Mergers & Acquisitions matters.
  • Thompson Reuters recognizes Sandeep for his Mergers & Acquisitions work.

 

Memberships

  • Bar Council of Maharashtra and Goa
  • The Bombay Incorporated Law Society
  • International Bar Association

 

Education

  • B.Com., University of Bombay (1991)
  • Advocate, LL.B., Bachelor of Law, University of Bombay (1994)
  • Solicitor, The Bombay Incorporated Law Society (1995)

 

Languages

  • English
  • Hindi
  • Gujarati

Some of the key assignments in these areas handled and being handled by Sandeep, amongst others, cover the following: –

  • Representing TRAFIGURA GROUP, SWITZERLAND in its Joint Venture with ROSENEFT and UCP INVESTMENT GROUP to acquire majority shares of ESSAR OIL LIMITED engaged in refinery business and subsequent sale of majority shares of NAYARA (ESSAR) OIL LIMITED to HARA CAPITAL, U.A.E. and GENERA, ITALY.
  • MTG GAMING AB, SWEDEN for acquisition of 100% shareholding in PLAYSIMPLE GAMES PRIVATE LIMITED (“PGPL”) from Indian Founders and private equity investors. PGPL is one of the leading free-to-play mobile word game developers in the world.
  • Representing DANAHER CORPORATION, USA (“Danaher”) in the India leg of the global acquisition and restructuring of the biopharma business of life sciences division from GENERAL ELECTRIC COMPANY, USA (“GE”).
  • Representing SAINT-GOBAIN, FRANCE in relation to acquisition of 100% shares of P. TWIGA LIMITED (“UPTL”) from its promoter shareholders. UPTL is engaged in the manufacturing of Industrial insulation products.
  • Representing GMS PHARMA (SINGAPORE) PTE. LTD., for sale of minority shareholding in STELIS BIOPHARMA PRIVATE LIMITED (“STELIS”) to MEDELLA HOLDINGS PTE. LTD, TPG GROUP. STELIS is a biopharmaceutical company and is involved in various drug manufacturing processes including manufacturing of vaccines.
  • Representing BUREAU VERITAS SINGAPORE PTE. LTD. (“BV”) in acquisition of majority shareholding of HI PHYSIX LABORATORY INDIA PRIVATE LIMITED (“HI PHYSIX INDIA”) from the individual shareholders of HI PHYSIX INDIA which is engaged in inspection and certification services.
  • Representing UK CLIMATE INVESTMENTS LLP to acquire and subsequent sale of minority equity shareholding of CLEAN MAX SOLAR.
  • Advising a leading global Private Equity Investor group, on acquisition and subsequent sale of minority equity stakes of another global energy investor, held in two Indian entities engaged in wind energy sector in India.

Disclaimer & Confirmation


As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, you acknowledge the following:

If you have any legal issues, you, in all cases, must seek independent legal advice.

We use cookies to enhance your experience. By continuing to visit this website you agree to our use of cookies.